Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 7 hours 10 minutes
FTSE 100
8,443.46
+9.70
(+0.12%)
FTSE 250
20,646.13
+0.75
(+0.00%)
AIM
789.02
-0.85
(-0.11%)
GBP/EUR
1.1614
-0.0008
(-0.07%)
GBP/USD
1.2524
-0.0001
(-0.01%)
Bitcoin GBP
50,019.06
+1,475.68
(+3.04%)
Calidi Biotherapeutics, Inc. (CLDI)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.2360
+0.0040
(+1.72%)
At close: 03:59PM EDT
0.2454
+0.01
(+3.98%)
After hours:
06:22PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
45
449
0
Cost of revenue
0
0
14
94
0
Gross profit
0
0
31
355
0
Operating expenses
Research development
13,008
13,008
7,257
4,674
3,182
Selling general and administrative
15,984
15,984
15,902
6,163
3,591
Total operating expenses
26,107
26,107
23,159
10,837
6,773
Operating income or loss
-26,107
-26,107
-23,128
-10,482
-6,773
Interest expense
1,069
1,069
158
614
163
Total other income/expenses net
656
656
-2,130
174
-997
Income before tax
-29,200
-29,200
-25,416
-10,922
-7,933
Income tax expense
16
16
11
11
4
Income from continuing operations
-29,216
-29,216
-25,427
-10,933
-7,937
Net income
-29,216
-29,216
-25,427
-10,933
-7,937
Net income available to common shareholders
-29,216
-29,216
-25,427
-10,933
-7,937
Basic EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Diluted EPS
-0.59
-1.73
-0.71
-0.30
-0.22
Basic average shares
35,907
16,887
35,907
35,907
35,907
Diluted average shares
35,907
16,887
35,907
35,907
35,907
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.